4.5 Review

Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights

Journal

BRAIN RESEARCH BULLETIN
Volume 193, Issue -, Pages 11-21

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2022.11.018

Keywords

Alzheimer?s disease; Astaxanthin; Bioactive compounds; Drug delivery; Fucoxanthin; Pathogenesis; Pharmacokinetic

Categories

Ask authors/readers for more resources

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with complex pathology. Natural products such as fucoxanthin and astaxanthin found in algae have shown promising potential in preventing and slowing down the progression of AD. These carotenoids exhibit neuroprotective properties through antioxidant and anti-inflammatory effects, as well as modulation of various targets involved in AD.
Alzheimer's disease (AD) is the most devastating neurodegenerative disorder affecting the elderly. The exact pathology of AD is not yet fully understood and several hallmarks such as the deposition of amyloid-beta, tau hyperphosphorylation, and neuroinflammation, as well as mitochondrial, metal ions, autophagy, and cholinergic dysfunctions are known as pathologic features of AD. Since no definitive treatment has been proposed to target AD to date, many natural products have shown promising preventive potentials and contributed to slowing down the disease progression. Algae is a promising source of novel bioactive substances known to prevent neurode-generative disorders including AD. In this context, fucoxanthin and astaxanthin, natural carotenoids abundant in algae, has shown to possess neuroprotective properties through antioxidant, and anti-inflammatory character-istics in modulating the symptoms of AD. Fucoxanthin and astaxanthin exhibit anti-AD activities by inhibition of AChE, BuChE, BACE-1, and MAO, suppression of A beta accumulation. Also, fucoxanthin and astaxanthin inhibit apoptosis induced by A beta 1-42 and H2O2-induced cytotoxicity, and modulate the antioxidant enzymes (SOD and CAT), through inhibition of the ERK pathway. Moreover, cellular and animal studies on the beneficial effects of fucoxanthin and astaxanthin against AD were also reviewed. The potential role of fucoxanthin and astaxanthin exhibits great efficacy for the management of AD by acting on multiple targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available